Vadim Alexander discusses Interim Results from Hemogenyx Pharmaceuticals

Sep 30, 11:22 AM

Vadim Alexandre, Head of Healthcare at SP Angel discusses Interim Results from, pre-clinical stage biopharmaceutical group, Hemogenyx Pharmaceuticals #HEMO

Vadim Alexandre, Head of Healthcare at SP Angel discusses Interim Results from, pre-clinical stage biopharmaceutical group, Hemogenyx Pharmaceuticals #HEMO

About Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The Company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.